Crisis specialist Sitrick and Company is representing New York Yankees third baseman Alex Rodriquez, who is denying a Miami New Times report that ties the 37-year-old to performance enhancing drugs.

The newspaper claims it received records from a former employee at a now shuttered Coral Gables, Fla., anti-aging clinic that allegedly lists drugs distributed to A-Rod and five other Major League baseball players.

The operator of the Biogenesis of America facility, Anthony Bosch, has criticized the MNT story as “filled with inaccuracies, innuendos and misstatements.” He also denies that he treated A-Rod.

Rodriguez, who recently had a second hip surgery, may be out for upcoming baseball season. The Yankees inked Rodriquez to a ten-year $275M contract in 2007.

S&C CEO Mike Sitrick and Terry Fahn, a senior member of the firm, are working with Rodriguez.